EPA-0682 – Investigator-rated symptomatological outcomes in...

EPA-0682 – Investigator-rated symptomatological outcomes in a phase 4 study of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder and impaired executive function

Adler, L., Raychaudhuri, A., Dirks, B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Year:
2014
Language:
english
Journal:
European Psychiatry
DOI:
10.1016/S0924-9338(14)78049-6
File:
PDF, 77 KB
english, 2014
Conversion to is in progress
Conversion to is failed